ArTS Archivio della ricerca di Trieste

LUCAFÒ, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.221
EU - Europa 5.392
AS - Asia 4.158
SA - Sud America 589
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 165
OC - Oceania 15
Totale 17.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.048
IT - Italia 1.473
SG - Singapore 1.433
PL - Polonia 1.414
CN - Cina 904
VN - Vietnam 489
DE - Germania 462
BR - Brasile 431
SE - Svezia 429
HK - Hong Kong 394
BD - Bangladesh 311
FR - Francia 267
FI - Finlandia 265
GB - Regno Unito 228
RU - Federazione Russa 176
KR - Corea 168
NL - Olanda 128
UA - Ucraina 121
IN - India 120
IE - Irlanda 80
TR - Turchia 78
CA - Canada 75
BG - Bulgaria 71
AR - Argentina 54
MA - Marocco 47
AT - Austria 45
BE - Belgio 45
MX - Messico 45
JP - Giappone 44
ES - Italia 31
SN - Senegal 31
ZA - Sudafrica 31
EC - Ecuador 27
SA - Arabia Saudita 26
ID - Indonesia 24
IQ - Iraq 23
PK - Pakistan 22
CO - Colombia 20
CH - Svizzera 17
PH - Filippine 17
CL - Cile 15
CZ - Repubblica Ceca 14
LT - Lituania 14
JM - Giamaica 13
PE - Perù 13
VE - Venezuela 13
AU - Australia 12
RS - Serbia 12
GR - Grecia 11
RO - Romania 11
SI - Slovenia 11
TH - Thailandia 11
EG - Egitto 10
MY - Malesia 10
PT - Portogallo 10
DK - Danimarca 9
DZ - Algeria 9
HR - Croazia 8
IL - Israele 8
JO - Giordania 8
PY - Paraguay 8
TN - Tunisia 8
UZ - Uzbekistan 8
HU - Ungheria 7
KW - Kuwait 7
NO - Norvegia 7
AZ - Azerbaigian 6
BA - Bosnia-Erzegovina 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
IR - Iran 6
KE - Kenya 6
AL - Albania 5
GT - Guatemala 5
LB - Libano 5
MD - Moldavia 5
BO - Bolivia 4
EU - Europa 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
CI - Costa d'Avorio 3
ET - Etiopia 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
MU - Mauritius 3
NG - Nigeria 3
OM - Oman 3
QA - Qatar 3
TW - Taiwan 3
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
KG - Kirghizistan 2
Totale 17.507
Salva come PNG Salva come JPEG
Città #
Warsaw 1.319
Ashburn 925
Singapore 837
Fairfield 563
Chandler 451
Trieste 440
Woodbridge 429
San Jose 381
Hong Kong 373
Ann Arbor 326
Houston 305
Wilmington 253
Munich 252
Seattle 248
Council Bluffs 233
Beijing 200
Cambridge 176
Helsinki 174
Seoul 151
Ho Chi Minh City 150
Los Angeles 135
Hanoi 128
Jacksonville 125
Hefei 124
Princeton 113
Boardman 112
Dallas 109
Milan 109
Santa Clara 105
Columbus 97
Chicago 94
Rome 87
New York 83
Lauterbourg 80
Moscow 77
Dublin 74
Sofia 69
Zgierz 64
London 60
Dearborn 55
Frankfurt am Main 52
The Dalles 51
Buffalo 50
Izmir 43
Casablanca 39
São Paulo 38
Brussels 36
Phoenix 34
Atlanta 33
Shanghai 33
Dakar 31
Lappeenranta 30
Vienna 29
San Diego 27
Dong Ket 26
Orem 26
Düsseldorf 25
Guangzhou 24
Mumbai 24
Turin 24
Falls Church 23
Naples 23
Redwood City 23
Denver 21
Charlotte 20
Manchester 20
Tokyo 20
Toronto 20
Amsterdam 19
Chennai 19
Johannesburg 19
Nuremberg 19
Brooklyn 18
Florence 18
Montreal 18
Venice 18
Washington 18
Bari 17
Redondo Beach 17
Bologna 16
Des Moines 16
Memphis 16
Stockholm 16
Turku 16
Bremen 15
Da Nang 15
Haiphong 15
Nottingham 14
Portsmouth 14
Jeddah 13
Jinan 13
Udine 13
Wroclaw 13
Belo Horizonte 12
Boston 12
Hangzhou 12
Mexico City 12
Nanjing 12
Brno 11
Guayaquil 11
Totale 11.418
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 549
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 517
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 496
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 491
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 476
Pharmacogenetics of thiopurines 454
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 423
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 384
Pharmacogenetics of treatments for inflammatory bowel disease 383
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 346
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 343
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 327
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 318
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 313
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 311
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 302
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 291
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 274
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 272
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 272
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 259
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 259
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 259
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 250
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 247
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 243
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 240
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 236
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 232
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 229
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 227
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells 226
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 213
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 209
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 206
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 204
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 200
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 194
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 192
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 191
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 191
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 190
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa 189
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 183
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 181
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 178
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 176
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 175
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 174
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 173
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 173
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 172
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 169
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 167
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 166
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 163
Neuron-Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation 161
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 161
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 161
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 160
Sedation and analgesia in children with cerebral palsy: a narrative review 159
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 156
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 156
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 150
Microbiota and drug response in inflammatory bowel disease 144
PIEZO1 Channels Modulate the Small Extracellular Vesicle Release in C2C12 Cells 139
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy 139
A patent review of anticancer glucocorticoid receptor modulators (2014-present) 138
Clinical application of thiopurine pharmacogenomics in pediatrics 132
Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications 129
Klebsiella pneumoniae contributes to altered cytotoxicity of thiopurines in vitro: Possible implications of biotransformation and bacterial metabolism 126
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress 125
NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease 124
Pharmacogenomics of antibiotics 116
Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction 107
Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients 107
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs 96
Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS 87
Unraveling the cellular mechanisms of thiopurine-induced pancreatitis in pediatric inflammatory bowel disease: Insights from induced pluripotent stem cell models 62
Inosine-Triphosphate-Pyrophosphatase Activity as a Potential Predictor of Methotrexate Remission in Juvenile Idiopathic Arthritis 62
Totale 17.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 0 0 54 80 40 85 78 28 100 89 36 197
2022/20231.324 120 215 94 197 115 209 15 119 129 27 48 36
2023/2024989 48 51 37 47 87 96 180 206 31 34 111 61
2024/20252.879 43 153 234 240 215 324 243 235 367 341 222 262
2025/20266.085 577 292 385 495 510 430 822 211 732 771 550 310
2026/2027823 298 321 204 0 0 0 0 0 0 0 0 0
Totale 17.975